CHRNA4: A Neuronal Acetylcholine Receptor Subunit Alpha-4 as A Drug Target or Biomarker

Target Name: CHRNA4

NCBI ID: G1137

CHRNA4: A Neuronal Acetylcholine Receptor Subunit Alpha-4 as A Drug Target or Biomarker

Unlocking the Potential of CHRNA4: A Review on Neuronal Acetylcholine Receptor Subunit Alpha-4 as a Drug Target or Biomarker

Abstract:

Neuronal acetylcholine receptor subunit alpha-4 (CHRNA4) is a protein that plays a crucial role in modulating various cellular processes in the central nervous system (CNS). It is expressed in high levels in the brain and is involved in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and chronic pain. This protein has also been identified as a potential drug target and biomarker for various neurological disorders. In this article, we will discuss the current research on CHRNA4, its potential drug targets, and its role as a biomarker in neurological disorders.

Introduction:

Neuronal acetylcholine receptor subunit alpha-4 (CHRNA4) is a transmembrane protein that is expressed in the brain and is involved in various neurological disorders. CHRNA4 is a member of the acetylcholine receptor subfamily, which is a family of G protein-coupled receptors that play a crucial role in modulating various cellular processes, including neurotransmitter signaling, ion channels, and intracellular signaling pathways.

CHRNA4 is involved in the regulation of various cellular processes in the CNS, including the modulation of neurotransmitter signaling, the regulation of ion channels, and the regulation of intracellular signaling pathways. It is also involved in the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and chronic pain.

Potential Drug Targets:

CHRNA4 has been identified as a potential drug target for various neurological disorders. One of the main reasons for its potential as a drug target is its involvement in the regulation of neurotransmitter signaling. CHRNA4 has been shown to play a role in the regulation of dopamine (6) and serotonin (7) signaling, which are involved in various neurological disorders, including Parkinson's disease and Alzheimer's disease.

Another potential drug target for CHRNA4 is its role in the regulation of ion channels. CHRNA4 has been shown to play a role in the regulation of K+ (9) and Na+ (10) ion channels, which are involved in the regulation of neuronal excitability and neurotransmission.

In addition to its role in neurotransmission, CHRNA4 has also been shown to play a role in the regulation of intracellular signaling pathways. CHRNA4 has been shown to be involved in the regulation of various intracellular signaling pathways, including the TGF-灏? pathway (12), the PI3K/Akt pathway (13), and the NF-kappa-B pathway.

Biomarker Potential:

CHRNA4 has also been identified as a potential biomarker for various neurological disorders. One of the main reasons for its potential as a biomarker is its involvement in the regulation of neurotransmission. CHRNA4 has been shown to play a role in the regulation of neurotransmission in the CNS, including the modulation of dopamine and serotonin signaling.

Another potential use of CHRNA4 as a biomarker is its involvement in the regulation of ion channels. CHRNA4 has been shown to play a role in the regulation of K+ and Na+ ion channels, which are involved in the regulation of neuronal excitability and neurotransmission.

Conclusion:

In conclusion, CHRNA4 is a protein that plays a crucial role in modulating various cellular processes in the CNS. Its involvement in the regulation of neurotransmission, ion channels, and intracellular signaling pathways makes it a potential drug target and biomarker for various neurological disorders. Further research is needed to fully understand the role of CHRNA4 in the CNS and to develop effective treatments for disorders associated with its dysfunction.

Protein Name: Cholinergic Receptor Nicotinic Alpha 4 Subunit

Functions: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane permeable to sodium ions

More Common Targets